##  [Key Considerations for Comparative Quality Studies for the Proposed Biosimilar Product in EU](/regulatory-radio/key-considerations-for-comparative-quality-studies-for-the-proposed-biosimilar-product-in-eu) 

- Subscribe:
- [Apple Podcasts](https://podcasts.apple.com/us/podcast/freyr-regulatory-radio/id1608849172)
- [Google Podcasts](https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkLnBvZGJlYW4uY29tL2ZyZXlyc29sdXRpb25zL2ZlZWQueG1s)
- [Spotify](https://open.spotify.com/show/4m38aNEhFY7uaCY4DcSssj?si=S4cJhnXKQn2PRiofh9D1sA&nd=1)
- [Podbean](https://freyrsolutions.podbean.com/%20)
- [Amazon Music](https://music.amazon.com/podcasts/200dc633-e32d-4718-a1f6-3f5180923c20/freyr-regulatory-radio)
- [Youtube](https://youtu.be/FVVjI07plRk)





# Episode 5

## Key Considerations for Comparative Quality Studies for the Proposed Biosimilar Product in EU

In the last episode of Freyr Regulatory Radio, Season 4, our experts discuss key considerations for Comparative Quality Studies for a proposed biosimilar product in the EU.

Furthermore, this episode throws light upon the criteria for the reference biological product and its evaluation.







 <a data-entity-id="3580" data-entity-op="like" data-entity-type="node" title="Like">Like</a> 5 

 <a class="disable-status" data-entity-id="3580" data-entity-op="dislike" data-entity-type="node" title="Dislike">Dislike</a> 0 

 



 0 Comments 

## Add new comment

  You must have JavaScript enabled to use this form.

 Your name  

    Comment 

 

[About text formats](/filter/tips)

#### Plain text

- No HTML tags allowed.
- Lines and paragraphs break automatically.
- Web page addresses and email addresses turn into links automatically.